Clinical trials

  • CND261 for ANCA-associated vasculitis (ANCA-IgG-positive, treatment-refractory)
  • Ipilimumab for Renal cell carcinoma (metastatic)
  • DT-101 for Major depressive disorder
  • TINZAPARIN SODIUM for Advanced pancreatic cancer
  • DEXMEDETOMIDINE for Procedural sedation
  • Valaciclovir hydrochloride for Herpes simplex virus type 2 meningitis | Herpes simplex meningitis
  • Testosterone
  • TULISOKIBART for Hidradenitis suppurativa
  • ADENO-ASSOCIATED VIRAL VECTOR SEROTYPE 9 CONTAINING THE HUMAN CTNNB1 GENE for CTNNB1 syndrome
  • (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYLCARBAMOYL)-QUINOLIN-6-YL)(METHYL)AMINO)-PROPYL)PIPERAZIN-1-YL)-2-OXOETHYL)-68GA-[1,4,7,10]-TETRAAZACYCLODODECANE-1,4,7-TRIYL)TRIACETATE for Peritoneal metastases
  • PEMBROLIZUMAB for Advanced cancer | Metastatic non-small cell lung cancer
  • BLU-808 for Chronic inducible urticaria | Chronic spontaneous urticaria